Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients

By              

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 693-699

Spandidos Publications

Access to resources Recommend Favorite

Urokinase Plasminogen Activator, a Strong Independent Prognostic Factor in Breast Cancer, Analysed in Steroid Receptor Cytosols with a Luminometric Immunoassay

By South Sweden Breast Cancer Group   Ferno M.   Bendahl P.-O.   Borg .   Brundell J.   Hirschberg L.   Olsson H.   Killander D.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 793-801

Elsevier

Access to resources Recommend Favorite

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

By Chung Hyun   Rha Sun   Park Joon   Yoo Nae   Kim Joo   Roh Jae   Min Jin   Lee Kyong   Kim Byung   Kim Jin  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 41-50

Springer Publishing Company

Access to resources Recommend Favorite

Elevated Plasma Levels of Urokinase Plasminogen Activator Receptor in Non-small Cell Lung Cancer Patients

By Pappot H.   Hoyer-Hansen G.   Ronne E.   Hansen H.H.   Brunner N.   Dano K.   Grondahl-Hansen J.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 867-872

Elsevier

Access to resources Recommend Favorite

Soluble Urokinase Plasminogen Activator Receptor in Preoperatively Obtained Plasma from Patients with Gynecological Cancer or Benign Gynecological Diseases

By Riisbro R.   Stephens R.W.   Brunner N.   Christensen I.J.   Nielsen H.J.   Heilmann L.   von Tempelhoff G.-F.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 523-531

Elsevier

Access to resources Recommend Favorite